Neurology Department, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Alzheimers Dis. 2022;89(3):893-901. doi: 10.3233/JAD-220594.
There are relatively few data on the genetic spectrum of Chinese frontotemporal dementia (FTD) population.
With the dementia cohort of Peking Union Medical College Hospital, we aim to illustrate the genetic spectrum of FTD patients, as well as the phenotypic heterogeneity of FTD-gene variant carriers.
204 unrelated, clinically diagnosed FTD patients of Chinese ancestry were enrolled. All the participants received demographic survey, history inquiry, physical examination, cognitive assessment, blood biochemical test, brain CT/MRI, and gene sequencing.
56.4% (115/204) participants were clinically diagnosed with behavioral variant of FTD, 20.6% (42/204) with nonfluent/agrammatic variant primary progressive aphasia (PPA), 20.1% (41/204) with semantic variant PPA, and 2.9% (6/204) with mixed variant PPA. 11.8% (24/204) subjects harbored the potential causative variants in FTD-related genes, including the MAPT (n = 7), TBK1 (n = 7), GRN (n = 2), TBK1+GRN (n = 1), VCP (n = 1), TARDBP (n = 1), UBQLN2 (n = 1), SQSTM1 (n = 1), DCTN1 (n = 1), HNRNPA1 (n = 1), and C9orf72 GGGGCC repeats (n = 1). The TBK1 T31fs, T457fs, K622fs, c.359-1G>A, the VCP P188T, and the GRN P50fs, P439fs were novel pathogenic/likely pathogenic variants. The TBK1 carriers showed a later disease onset and a higher incidence of parietal atrophy relative to the MAPTcarriers.
There is genetic and clinical heterogeneity among Chinese FTD population. The TBK1 has a high mutation frequency in Chinese FTD patients.
关于中国额颞叶痴呆(FTD)人群的遗传谱数据相对较少。
我们通过北京协和医学院医院的痴呆队列,旨在阐明 FTD 患者的遗传谱,以及 FTD-基因突变携带者的表型异质性。
共纳入 204 例汉族裔、临床诊断的 FTD 患者。所有参与者均接受了人口统计学调查、病史询问、体格检查、认知评估、血生化检查、脑 CT/MRI 和基因测序。
56.4%(115/204)的参与者被临床诊断为行为变异型 FTD,20.6%(42/204)为非流利/语法障碍性原发性进行性失语(PPA),20.1%(41/204)为语义性 PPA,2.9%(6/204)为混合性 PPA。11.8%(24/204)的患者携带 FTD 相关基因的潜在致病突变,包括 MAPT(n=7)、TBK1(n=7)、GRN(n=2)、TBK1+GRN(n=1)、VCP(n=1)、TARDBP(n=1)、UBQLN2(n=1)、SQSTM1(n=1)、DCTN1(n=1)、HNRNPA1(n=1)和 C9orf72 GGGGCC 重复(n=1)。TBK1 的 T31fs、T457fs、K622fs、c.359-1G>A、VCP 的 P188T 和 GRN 的 P50fs、P439fs 为新型致病性/可能致病性突变。与 MAPT 携带者相比,TBK1 携带者的发病年龄较晚,顶叶萎缩的发生率更高。
中国 FTD 人群存在遗传和临床异质性。TBK1 在中国人 FTD 患者中的突变频率较高。